Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Reza Alimohammadi

Reza Alimohammadi profile photo picture

Postdoctoral Researcher 2

Institution: Medical College of Wisconsin
Department: Microbiology and Immunology

Publications (13)

  • ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation. (Cheng Q, Choi HJ, Wu Y, Yuan X, Pugel A, Tian L, Hendrix M, Fu D, Alimohammadi R, Liu C, Yu XZ) J Clin Invest 2025 Dec 01;135(23) PMID: 41026526 PMCID: PMC12646671 SCOPUS ID: 2-s2.0-105023549695 09/30/2025       2 Citations
  • Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up. (Salehi M, Alavi Darazam I, Nematollahi A, Alimohammadi M, Pouya S, Alimohammadi R, Khajavirad N, Porgoo M, Sedghi M, Mahdi Sepahi M, Azimi M, Hosseini H, Mahmoud Hashemi S, Dehghanizadeh S, Khoddami V) Int Immunopharmacol 2024 Jun 15;134:112192 PMID: 38761778 SCOPUS ID: 2-s2.0-85193453984 05/19/2024       4 Citations
  • Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME). (Alimohammadi M, Ghaffari-Nazari H, Alimohammadi R, Bakhshandeh M, Jalali SA, Rezaei N) Avicenna J Med Biotechnol 2023;15(4):209-215 PMID: 38078341 PMCID: PMC10709758 SCOPUS ID: 2-s2.0-85171537993 12/11/2023       4 Citations
  • Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model. (Alimohammadi R, Mahmoodi Chalbatani G, Alimohammadi M, Ghaffari-Nazari H, Rahimi A, Mortaz E, Mossafa N, Boon L, Jalali SA) Sci Rep 2023 Feb 11;13(1):2472 PMID: 36774400 PMCID: PMC9922272 SCOPUS ID: 2-s2.0-85147835309 02/12/2023       17 Citations
  • SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates. (Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Sattari Khavas D, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, Rahmati A, Razzaznian M, Tirandazi V, Tat M, Borzouee F, Sadeghi H, Haji Mohammadi M, Rastegar L, Safar Sajadi SM, Ehsanbakhsh H, Bazmbar H, Baghernejadan Z, Shams Nouraei M, Pazooki P, Pahlavanneshan M, Alishah K, Nasiri F, Mokhberian N, Mohammadi SS, Akar S, Niknam H, Azizi M, Ajoudanian M, Moteallehi-Ardakani MH, Mousavi Shaegh SA, Ramezani R, Salimi V, Moazzami R, Hashemi SM, Dehghanizadeh S, Khoddami V) NPJ Vaccines 2022 Sep 02;7(1):105 PMID: 36056015 PMCID: PMC9438359 SCOPUS ID: 2-s2.0-85137602277 09/03/2022       13 Citations
  • Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments. (Rostami E, Bakhshandeh M, Ghaffari-Nazari H, Alinezhad M, Alimohammadi M, Alimohammadi R, Mahmoodi Chalbatani G, Hejazi E, Webster TJ, Tavakkol-Afshari J, Jalali SA) PLoS One 2022;17(8):e0273547 PMID: 36018888 PMCID: PMC9417014 SCOPUS ID: 2-s2.0-85137127092 08/27/2022       6 Citations
  • Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model. (Ghaffari-Nazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, Mahmoodi Chalbatani G, Tavakkol-Afshari J, Amir Jalali S) Int Immunopharmacol 2022 Jul;108:108737 PMID: 35417831 SCOPUS ID: 2-s2.0-85127784658 04/14/2022       21 Citations
  • Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis. (Mousavi MJ, Shayesteh MRH, Jamalzehi S, Alimohammadi R, Rahimi A, Aslani S, Rezaei N) J Res Med Sci 2021;26:22 PMID: 34221051 PMCID: PMC8240549 07/06/2021    
  • Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy. (Alimohammadi R, Alibeigi R, Nikpoor AR, Chalbatani GM, Webster TJ, Jaafari MR, Jalali SA) Int J Nanomedicine 2020;15:5279-5288 PMID: 32801691 PMCID: PMC7394514 SCOPUS ID: 2-s2.0-85089711156 08/18/2020       25 Citations
  • Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model. (Golchin S, Alimohammadi R, Rostami Nejad M, Jalali SA) J Cell Physiol 2019 Nov;234(11):19866-19874 PMID: 30941773 SCOPUS ID: 2-s2.0-85069662394 04/04/2019       33 Citations
  • Strategies toward rheumatoid arthritis therapy; the old and the new. (Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S) J Cell Physiol 2019 Jul;234(7):10018-10031 PMID: 30536757 SCOPUS ID: 2-s2.0-85058017361 12/12/2018       374 Citations
  • In vitro modulatory effect of dehydroepiandrosterone sulfate on apoptosis and expression of apoptosis-related genes in patients with systemic lupus erythematosus. (Yousefi B, Rastin M, Hatef MR, Shariati J, Alimohammadi R, Mahmoudi M) J Cell Physiol 2019 Aug;234(8):12676-12684 PMID: 30536399 SCOPUS ID: 2-s2.0-85058034122 12/12/2018       9 Citations
  • Bare surface of gold nanoparticle induces inflammation through unfolding of plasma fibrinogen. (Kharazian B, Lohse SE, Ghasemi F, Raoufi M, Saei AA, Hashemi F, Farvadi F, Alimohamadi R, Jalali SA, Shokrgozar MA, Hadipour NL, Ejtehadi MR, Mahmoudi M) Sci Rep 2018 Aug 22;8(1):12557 PMID: 30135553 PMCID: PMC6105630 SCOPUS ID: 2-s2.0-85052533024 08/24/2018       48 Citations
    • Last update: 10/01/2025